Taylor, Cottrill, Erickson & Associates, Inc. Medexus Pharmaceuticals Inc CO Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

  • $359 Million
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$1.5 - $2.56 $52,500 - $89,600
-35,000 Closed
0 $0
Q1 2022

May 03, 2022
BUY
$1.97 - $2.67 $19,700 - $26,700
10,000 Added 40.0%
35,000 $88,000
Q4 2021

Feb 03, 2022
SELL
$1.91 - $2.94 $5,730 - $8,820
-3,000 Reduced 10.71%
25,000 $50,000
Q3 2021

Oct 15, 2021
BUY
$2.09 - $6.22 $16,720 - $49,760
8,000 Added 40.0%
28,000 $66,000
Q2 2021

Jul 20, 2021
BUY
$5.69 - $6.61 $34,140 - $39,660
6,000 Added 42.86%
20,000 $118,000
Q1 2021

Apr 14, 2021
BUY
$5.26 - $7.6 $21,040 - $30,400
4,000 Added 40.0%
14,000 $88,000
Q3 2020

Oct 09, 2020
BUY
$2.56 - $3.9 $25,600 - $39,000
10,000 New
10,000 $29,000

About MEDEXUS PHARMACEUTICALS INC CO

MEDXF Quotes by TradingView
  • Ticker MEDXF
More about MEDXF
Track This Portfolio

Track Taylor, Cottrill, Erickson & Associates, Inc. Portfolio

Follow Taylor, Cottrill, Erickson & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email